NCT07062848Active, not recruiting
An Observational Study Using Artificial Intelligence (AI) Algorithms on Electrocardiography (ECG), Point-of-care Ultrasound (POCUS), and Transthoracic Echocardiophy (TTE) to Estimate the Under-diagnosis of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Across a Diverse Range of US Health Systems.
The Transthyretin Amyloid Cardiomyopathy Early Detection With Artificial Intelligence (TRACE-AI) Network Study
Source: ClinicalTrials.gov · Last updated 29 Jul 2026
Brief summary (registry, in English)
This is a multi-center, observational study with the overall objective to examine the scale of under-diagnosis for transthyretin amyloid cardiomyopathy (ATTR-CM) across a broad range of diverse health systems in the US using a fully federated deployment of an artificial intelligence (AI) toolkit of algorithms that detect ATTR-CM on electrocardiography (ECG), point-of-care ultrasound (POCUS), and transthoracic echocardiography (TTE).
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 1500000 (estimated)
- First submitted
- 3 Jul 2025
- Start date
- 24 Jan 2025
- Primary completion date
- Jan 2027
- Lead sponsor
- Yale University
- Diseases
- Amyloidosis
- NCT number
- NCT07062848
What you commit to
- Study type: Observational
- Planned participants: 1500000
- From 24 Jan 2025 to the primary completion date, Jan 2027
- 12 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- 'Cases': ATTR-CM diagnosis defined by ICD-10 codes (Table 1) OR abnormal bone scintigraphy testing consistent with ATTR-CM OR treatment with an approved transthyretin stabilizer or other ATTR-CM-specific therapy
- 'Controls': any individuals not meeting the case definition. In these participants, we will consider all eligible ECG, POCUS, or TTE studies performed up to 12 months before diagnosis (first date of ICD code appearance, abnormal bone scintigraphy or treatment onset, whichever happened first) and any time after. 'Controls' will be drawn from ECGs, POCUS, or TTE studies performed in individuals not meeting the 'case' criteria above, including individuals who have never undergone dedicating testing or those who underwent e.g., bone scintigraphy, but with negative (or equivocal) findings.
- Secondary Objective 2:
- Additional inclusion criteria:
Age
- Unavailable key demographics (age, gender, race, ethnicity)
- For subgroup analyses: when evaluating the prevalence of probable ATTR-CM status across demographic groups, we will exclude those with missing baseline demographic information (age, sex, race, geographic region).
- Secondary Objective 1:
- Additional inclusion criteria:
Other
- Individuals who have opted out of research studies
- Objective-specific inclusion and exclusion criteria:
- Primary Objective:
- Additional exclusion criteria:
- Having at least two years of follow-up time between the index test (ECG, POCUS, or TTE) and the date of analysis.
- Having at least one healthcare encounter every two years across care settings from their first entry into the cohort through death or end of the follow-up period.
Who the study is looking for
- Age 50-95
- At least one retrievable ECG and/or 2D echo file (DICOM or equivalent video file) from EHR.
Criteria the registry did not label
- Broad inclusion and exclusion criteria across all 3 objectives:
Age in the registry: 50 years to 95 years · Sex: All · Does not accept healthy volunteers
Sites (12)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Medical University of South Carolina (MUSC) Health Coordinator of this site? Confirm its status | Charleston | United States | Unknown status |
| University of Virginia School of Medicine Coordinator of this site? Confirm its status | Charlottesville | United States | Unknown status |
| The University Of Chicago Coordinator of this site? Confirm its status | Chicago | United States | Unknown status |
| UT Southwestern Medical Center Coordinator of this site? Confirm its status | Dallas | United States | Unknown status |
| Henry Ford Health Coordinator of this site? Confirm its status | Detroit | United States | Unknown status |
| Houstin Methodist Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
| Yale-New Haven Health System Coordinator of this site? Confirm its status | New Haven | United States | Unknown status |
| Mount Sinai Coordinator of this site? Confirm its status | New York | United States | Unknown status |
| University of California - San Francisco (UCSF) Health Coordinator of this site? Confirm its status | San Francisco | United States | Unknown status |
| University of Washington Medicine Coordinator of this site? Confirm its status | Seattle | United States | Unknown status |
| Montefiore Coordinator of this site? Confirm its status | The Bronx | United States | Unknown status |
| Providence Health Coordinator of this site? Confirm its status | Tigard | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.